Nitric oxide test during cardiac catheterization decreases the serum concentrations of S100B protein in adult patients with idiopathic pulmonary hypertension.
OBJECTIVE
Cardiac catheterization (CC) is a life-threatening procedure in adult patients. Complicated by idiopathic arterial pulmonary hypertension (IPAH), there is a potential risk of central nervous system (CNS) damage. We measured serum levels of a well-established brain damage marker, namely S100B, collected before, during and after CC in adult patients in whom the nitric oxide (NO) test had been performed.


METHODS
In 12 adult patients who had undergone CC for IPAH diagnosis, we recorded clinical and standard monitoring procedures (laboratory variables and echocardiographic patterns) and serum concentrations of S100B before (time 0), during (time 1) and after the NO test (time 2) and at 24 h after (time 3) the procedure in samples obtained from the systemic and pulmonary circulation. Patients were subdivided into NO test responders (n=6) and non-responders (n=6). Neurological evaluation was performed at admission and at discharge from hospital.


RESULTS
Adult patients subjected to CC showed no overt neurological injury at discharge from hospital. No significant differences (p > 0.05 for all) in S100B serum levels between groups at times 0, 1 and 3 have been shown independently from the sampling site. It was noteworthy that the concentration of protein in the responders group at time 2 was significantly decreased (p < 0.05, for all) compared to the responder group and to baseline values. A significant correlation was found between arterial oxygen partial pressure and individual S100B concentration in the pulmonary and systemic bloodstream in the entire study group (R = -0.66 and R = 0.71, respectively; p < 0.05, for both).


CONCLUSIONS
The data suggest that S100B protein assessment, as well as the NO test, may be useful when monitoring possible CNS damage during CC in patients with IPAH, and may also be valuable in relation to brain functions, especially when performed as an emergency procedure in severely hypoxic patients.
Ussia
G P
GP
Department of Heart, Ferrarotto Hospital, University of Catania, Catania, Italy.
Tina
L G
LG
Scarabelli
M
M
Nigro
F
F
Li Volti
G
G
Cavallaro
D
D
Salvo
V
V
Mulè
M
M
Caruso
E
E
Tamburino
C
C
Gazzolo
D
D
D015415:Biomarkers / Q000032:analysis / Q000097:blood; D006328:Cardiac Catheterization / Q000009:adverse effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications*; D020925:Hypoxia-Ischemia, Brain / Q000097:blood / Q000175:diagnosis* / Q000209:etiology*; D008875:Middle Aged; D009414:Nerve Growth Factors / Q000097:blood* / Q000187:drug effects; D009569:Nitric Oxide / Q000009:adverse effects* / Q000097:blood; D011379:Prognosis; D015203:Reproducibility of Results; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000097:blood* / Q000187:drug effects
D015415:Biomarkers; D009414:Nerve Growth Factors; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins; C579160:S100B protein, human; D009569:Nitric Oxide